Merck & Co., Inc. Expands Global Access to Once-Monthly Alimatravir
RAHWAY, N.J., July 24, 2026 Merck has announced an ambitious global access strategy for alimatravir (MK-8527), its investigational once-monthly...
Once Monthly Pill
Advertisement
Advertisement
